Navigation Links
Amgen and Onyx Pharmaceuticals Announce Upcoming Data Presentations at 55th American Society of Hematology Annual Meeting
Date:11/7/2013

rapy in Waldenstrom's Macroglobulinemia

  • Dr. Steven Peter Treon, Bing Center for Waldenstrom Macroglobulinemia, Dana-Farber Cancer Institute
  • Monday, December 9, 6:15 pm CT, 393-394
  • Oral presentation: Myeloma: Therapy, excluding Transplantation: Advances in Multiple Myeloma and Plasma Cell Leukemia
  • Abstract # 757

PRISM data highlights:

A Novel Bruton's Tyrosine Kinase Inhibitor CC-292 in Combination with the Proteasome Inhibitor Carfilzomib Impacts Multiple Myeloma Bone Microenviroment with Resultant Anti-myeloma Activity

  • Dr. Homare Eda, MGH Cancer Center, Massachusetts General Hospital
  • Monday, December 9, 5:15 pm CT, 388-390
  • Oral presentation: Myeloma: Biology and Pathophysiology, excluding Therapy: Bone Marrow Microenvironment and Myeloma Session
  • Abstract # 682

Phase 1 Study of the Novel Kinesin Spindle Protein Inhibitor ARRY-520 + Carfilzomib (Car) in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM)

  • Dr. Jatin Shah, The University of Texas MD Anderson Cancer Center
  • Saturday, December 7, 5:30 pm - 7:30 pm CT, Hall G
  • Poster presentation: Myeloma: Therapy, excluding Transplantation: Poster I
  • Abstract # 1982

Inhibition of Autophagy by ACY-1215, a Selective HDAC 6 Inhibitor Accelerates Carfilzomib-Induced Cell Death in Multiple Myeloma

  • Dr. Yuko Mishima, Massachusetts General Hospital Cancer Center
  • Monday, December 9, 6:00 pm - 8:00 pm CT, Hall G
  • Poster presentation: Myeloma: Pathophysiology and Pre-Clinical Studies, excluding Therapy: Poster III
  • Abstract # 4431

Dual Inhibition of M
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
2. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
3. Amgen Announces 2012 First Quarter Dividend
4. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
5. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
6. Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
7. Amgen to Acquire Micromet
8. Amgen to Present at the Leerink Swann Global Healthcare Conference
9. Amgen Announces 2012 Third Quarter Dividend
10. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
11. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... , May 5, 2015  Renova™ Therapeutics, a ... heart failure and other chronic diseases, has engaged ... analysis designed to reflect the healthcare patterns of ... model will be used to characterize the impact ... have on those groups of patients and the ...
(Date:5/5/2015)... , May 5, 2015 ImmunoCellular Therapeutics, ... Andrew Gengos , President and Chief Executive Officer, ... 2015. DATE:  Thursday, May 7, 2015     ... http://VirtualInvestorConferences.com > click the red "register/ watch ... live, interactive online event where investors are invited ...
(Date:5/5/2015)... May 05, 2015 A comment period ... wide range of key photonics technologies – regulations that ... of U.S. industry. To help the community understand and ... May on the proposed changes to U.S. Munitions ... by International Traffic in Arms Regulations (ITAR). , For ...
(Date:5/5/2015)... DUBLIN , May 05, 2015 Research ... announced the addition of the "Clinical Laboratory, ... and Forecast 2015 to 2019 - Global Version" ... technical developments especially in the area of molecular ... dynamic, growing and evolving world market that is ...
Breaking Biology Technology:RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3ImmunoCellular Therapeutics to Webcast Live at VirtualInvestorConferences.com on May 7 2Comments needed now from photonics industry on revisions of U.S. export rules 2Comments needed now from photonics industry on revisions of U.S. export rules 3Comments needed now from photonics industry on revisions of U.S. export rules 4Global Clinical Laboratory, Molecular Diagnostics and Genomic Testing Services Market Trends and Forecast 2015 to 2019 2
... , , , PRINCETON, ... Company) (OTC Bulletin Board: DORB), a late-stage biopharmaceutical company, announced ... Officer, will present at the Rodman & Renshaw 11th Annual ... at 4:55 PM on Thursday, September 10, 2009 in the ...
... - OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ) announced today that ... , , - Rodman & Renshaw 11th ... September 10, 2009 at 12:30 p.m. Eastern Time in the Fahnestock Salon, ... Hotel in New York City., - Thomas ...
... 2 Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Robert W. Baird & Co. 2009 Health Care Conference ... 2009 Health Care Conference in New York, New York, on September 9, 2009 ... Thomas Weisel Partners Healthcare Conference , Subsequently, Onyx will ...
Cached Biology Technology:DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 2DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 3DOR BioPharma to Present at the Rodman & Renshaw Annual Global Investor Healthcare Conference 4OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences 2Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences 2
(Date:4/2/2015)... According to preliminary estimates Fingerprint ... higher than 125 MSEK. This exceeds the guidance provided ... revenues for Q1 2015 would be in line with ... 2014. The operating result for the first quarter is ... report will as previously communicated be published on May ...
(Date:4/1/2015)... Conn. , Apr. 1, 2015  NXT-ID, Inc. ... biometric authentication company focused on the growing mobile commerce ... of Wocket smart wallets is underway to early access ... access group includes usage at retail outlets including Walmart, ... Pharmacy. Users report Wocket was accepted at all outlets ...
(Date:3/31/2015)... , March 31, 2015  Elephant Talk Communications Corp. ... global provider of Software Defined Network Architecture (ET Software ... total revenue of approximately $20.4 million for the year ... $19.5 million for the year ended December 31, 2013. ... the Company had completed its multi-year transition away from ...
Breaking Biology News(10 mins):Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 2Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 3Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 4Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 5Elephant Talk Reports 2014 Fourth Quarter and Year End Financial Results 6
... built at Scripps Institution of Oceanography at UC San ... state of all world oceans simultaneously is approaching its ... network of sensor-bearing profiling floats measures ocean water temperature, ... The Argo Steering Committee, the international panel of scientists ...
... living and dead organisms could serve as a relatively fast, ... ecosystems. The University of Chicago,s Susan Kidwell explains how measuring ... ecological tool in the Oct. 26 early online edition of ... affect ecosystems in many different ways, but the effects of ...
... and their colleagues have uncovered evidence of when Earth ... the one we breathe today. The study suggests ... of reverse-greenhouse effect 500 million years ago that cooled ... a burst of oxygen into the atmosphere. That ...
Cached Biology News:Unprecedented global measurement network achieves full coverage of oceans 2Unprecedented global measurement network achieves full coverage of oceans 3Dead clams tell many tales 2Dead clams tell many tales 3Dead clams tell many tales 4Researchers find origin of 'breathable' atmosphere half a billion years ago 2Researchers find origin of 'breathable' atmosphere half a billion years ago 3Researchers find origin of 'breathable' atmosphere half a billion years ago 4
... recognizes murine IRF7 protein, and ... related IRF proteins. Reactivity of ... protein was confirmed by western ... cells transfected with IRF7. Reactivity ...
...
EMBP (FL-222)...
Rabbit anti-T-box 6...
Biology Products: